Skip to main content
. Author manuscript; available in PMC: 2024 Jul 30.
Published in final edited form as: Cancer Epidemiol. 2022 Feb 1;77:102117. doi: 10.1016/j.canep.2022.102117

Fig. 1.

Fig. 1.

Median fluorescence intensity (MFI) values for BGLF2 and BXLF1 IgA and IgG antibodies. MFI values for all incident cases were split into Epstein-Barr virus small RNA 1 in situ hybridization (EBER-ISH) positive cases, EBER-ISH negative cases, cases with unknown EBER-ISH status and controls. Cut-offs are based on receiver operating characteristic (ROC) analysis to yield 90% seronegatives in the control group, i.e. 90% specificity.